-
Orthofix releases study on additional therapy for lumbar spinal fusion procedures
Spine and orthopedic products company Orthofix released new data on pulsed electromagnetic field stimulation, an additional therapy to lumbar spinal fusion procedures for patients at risk for pseudarthrosis. -
Life Spine settles litigation with Aegis Spine
Life Spine settled its litigation agianst Aegis Spine and secured a court order permanently prohibiting marketing or sales of AccelFix-XT devices in the U.S., according to a Dec. 21 news release. -
Ulrich Medical gets expanded indications for minimally invasive spine system
Ulrich Medica USA earned FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems, the company said Dec. 20. -
ZimVie to sell spine business for $375M
ZimVie is selling its spine business to HIG Capital for $375 million. -
10 spine, orthopedic patent disputes to know
There have been several spine and orthopedic legal disputes involving device patents in the last two years. Some have involved different companies, and others have involved surgeons. -
VA hospitals add Premia Spine's TOPS system
Premia Spine's TOPS System is now available at Veterns Affairs hospitals across the U.S., the devicemaker said Dec. 15. -
200+ spine medtech FDA clearances in 2023
The Food and Drug Administration cleared more than 200 spine-related devices and technologies with 510(k) approval in 2023. -
5 medtech notes: Premia Spine, Stryker and more
Here five developments from spine and orthopedic devicemakers since Dec. 13: -
ZimVie spine system gets cleared for use with Brainlab
ZimVie's Vital spinal fixation system was FDA cleared for use with Brainlab's spine and trauma navigation, according to a Dec. 12 news release. -
Orthofix names 3 independent directors
Orthofix named three independent directors to its board, the devicemaker said Dec. 12. -
Spinal Simplicity gets FDA nod for sacroiliac joint system
Spinal Simplicity's Liberty-SI Lateral implant system earned FDA 510(k) clearance, the devicemaker said Dec. 11. -
Orthofix in the headlines
Here are four moves from medical device company Orthofix that Becker's has reported on since Nov. 6: -
Stryker to nominate Starbucks exec to board
Stryker plans to nominate Rachel Ruggeri for election to its board of directors, the company said Dec. 7. -
$1.7M verdict against former NuVasive employee upheld
A former medical device sales representative for NuVasive was ordered to pay more $1.7 million to the company after an appeals court upheld an earlier verdict, SHRM reported Dec. 5. -
6-month data for Aurora Spine's Zip fusion implant is out: 4 notes
Aurora Spine's Zip fusion implant was found to be effective after six months, according to a study in the Journal of Pain Research. -
Nevro acquires spine company
Nevro acquired Vyrsa Technologis, a company focused on sacroiliac joint fusion, according to a Nov. 30 news release. -
How well-positioned is Orthofix for 2024?
With its SeaSpine merger sealed and a new leader at the helm, Orthofix had a busy 2023. Here's what to know going into next year: -
6 big deals shaking up the spine, orthopedic industry
Here are six major acquisitions Becker's has reported on since Sept. 1: -
4 things to know about Orthofix's new CEO
Massimo Calafiore was recently named as CEO of Orthofix, replacing an interim leader installed in September. Here are four things to know about him: -
How well-positioned is Globus Medical for 2024?
Following a more than $1 billion-revenue year in 2022, Globus Medical had high expectations for 2023. This year, the company completed a multibillion-dollar merger and surpassed previous quarterly earnings.
Page 6 of 189